Volume 23, Number 6—June 2017
Research
Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015–2016
Table 3
Annual incidence and proportions of penicillin-nonsusceptible 35B pneumococcal isolates causing IPD, United States, 1999–2015*
Year | Surveillance population | % CIS | No. 35B isolates from patients by age, y |
Relative incidence of 35B IPD† | Pen MIC, μg/mL |
penNS 35B isolates/penS 35B isolates | |||
---|---|---|---|---|---|---|---|---|---|
<5 | ≥5 | >2 | 0.12−1 | <0.06 | |||||
1998 | 17,383,935 | 86.1 | 3 | 18 | 1.40 | 9 | 5 | 7 | 2.0 |
1999 | 18,550,681 | 87.0 | 2 | 18 | 1.24 | 8 | 3 | 9 | 1.2 |
2000 | 19,821,607 | 86.3 | 4 | 21 | 1.46 | 7 | 9 | 9 | 1.8 |
2001 | 22,479,308 | 88.1 | 2 | 40 | 2.12 | 14 | 18 | 10 | 3.2 |
2002 | 25,051,246 | 87.6 | 2 | 34 | 1.64 | 20 | 8 | 8 | 3.5 |
2003 | 25,264,246 | 91.4 | 11 | 49 | 2.56 | 22 | 26 | 11 | 4.4 |
2004 | 27,419,898 | 87.9 | 15 | 69 | 3.49 | 44 | 25 | 15 | 4.6 |
2005 | 27,816,784 | 89.5 | 11 | 57 | 2.73 | 35 | 18 | 15 | 3.5 |
2006 | 28,204,455 | 86.7 | 1 | 65 | 2.70 | 37 | 15 | 14 | 3.7 |
2007 | 28,579,312 | 87.5 | 5 | 83 | 3.52 | 51 | 23 | 14 | 5.3 |
2008 | 28,856,774 | 86.7 | 12 | 80 | 3.68 | 62 | 16 | 14 | 5.6 |
2009 | 29,206,528 | 89.8 | 8 | 70 | 2.97 | 45 | 16 | 17 | 3.6 |
2010 | 29,757,552 | 90.2 | 4 | 67 | 2.65 | 52 | 14 | 5 | 13.2 |
2011 | 30,075,050 | 90.3 | 11 | 77 | 3.28 | 71 | 7 | 10 | 7.8 |
2012 | 30,356,544 | 90.6 | 13 | 101 | 4.14 | 94 | 14 | 6 | 18.0 |
2013 | 30,604,240 | 88.7 | 15 | 114 | 4.75 | 94 | 25 | 10 | 11.9 |
2014 | 31,328,211 | 88.2 | 16 | 116 | 4.78 | 104 | 22 | 6 | 21.0 |
2015 | 31,977,800 | 92.0 | 10 | 121 | 4.45 | 101 | 24 | 6 | 20.8 |
*CIS, case isolates serotyped; IPD, invasive pneumococcal disease.
†Estimated cases/million = total 35Bs x 100/% CIS surveillance population/1,000,000.